Legit Protein Peptide Hormones 99.6% Purity Tesamorelin 2mg/vial CAS 218949-48-5

Basic Information

Όνομα προϊόντος: Tesamorelin

Περιγραφή:

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.
Tesamorelin ( also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy.
p; tendon fibroblasts in a dose-dependent manner as revealed by transwell filter migration assay. BPC 157 also dose dependently accelerated the spreading of tendon fibroblasts on culture dishes. The F-actin formation as detected by FITC-phalloidin staining was induced in BPC 157-treated fibroblasts. The protein expression and activation of FAK and paxillin were determined by Western blot analysis, and the phosphorylation levels of both FAK and paxillin were dose dependently increased by BPC 157 while the total amounts of protein was unaltered. In conclusion, BPC 157 promotes the ex vivo outgrowth of tendon fibroblasts from tendon explants, cell survival under stress, and the in vitro migration of tendon fibroblasts, which is likely mediated by the activation of the FAK-paxillin pathway.
nbsp; was responsible for pituitary stimulation. In 1999 researchers Goa and Prakash checked sermorelin GH as provocative tasting method for deficiency of endogenous G-hormone.
The most known features of this research compound are increasing lean muscular tissue mass, reducing fat, increasing bone tissue density and even enhancing functioning of immune system. It complies with certain amino-segment of natural long-chained GHrh. Sermorelin helps to convert exceeded volume of GH by liver into IGF-1.

Εφαρμογή

Tesamorelin is a peptide called growth hormone releasing factor (GHRF), which produces and spreads growth hormone in the body, which helps to increase metabolism, reduce abdominal fat, improve body shape and use energy.

Tesamorelin is a synthetic growth hormone-releasing factor that stimulates the pituitary secretion of growth hormone; this indirect method appears to maintain a more stable natural level, such as the CJC-1295 DAC. Clinical trials have shown that tasamorelin significantly reduces abdominal fat than human growth hormone itself has less side effects, although abdominal fat may be returned after Tesamorlein withdrawal.

Επικοινώνησε τώρα